NDC 62135-496

Griseofulvin MICROSIZE

Griseofulvin

Griseofulvin MICROSIZE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Chartwell Rx, Llc.. The primary component is Griseofulvin.

Product ID62135-496_e1015d4f-428a-4b66-b55b-aabc86d223d3
NDC62135-496
Product TypeHuman Prescription Drug
Proprietary NameGriseofulvin MICROSIZE
Generic NameGriseofulvin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1971-09-09
Marketing CategoryANDA / ANDA
Application NumberANDA060569
Labeler NameChartwell RX, LLC.
Substance NameGRISEOFULVIN
Active Ingredient Strength500 mg/1
Pharm ClassesDecreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 62135-496-01

100 TABLET in 1 BOTTLE (62135-496-01)
Marketing Start Date2020-12-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Griseofulvin MICROSIZE" or generic name "Griseofulvin"

NDCBrand NameGeneric Name
62135-496Griseofulvin MICROSIZEgriseofulvin
0884-0763Gris-PEGgriseofulvin
0884-0773Gris-PEGgriseofulvin
53808-0261Gris-PEGGRISEOFULVIN
0472-0013GriseofulvinGriseofulvin
0713-0850GriseofulvinGriseofulvin
0781-5514GriseofulvinGriseofulvin
0781-5515GriseofulvinGriseofulvin
42794-012GriseofulvinGriseofulvin
42794-013GriseofulvinGriseofulvin
42794-014GriseofulvinGriseofulvin
64980-184GriseofulvinGriseofulvin
64980-185GriseofulvinGriseofulvin
64980-186GriseofulvinGriseofulvin
68682-519GriseofulvinGriseofulvin
68682-520GriseofulvinGriseofulvin
62135-494Ultramicrosize GriseofulvinGriseofulvin
62135-495Ultramicrosize GriseofulvinGriseofulvin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.